Page last updated: 2024-08-22

clodronic acid and alpha-Galactosidase A Deficiency

clodronic acid has been researched along with alpha-Galactosidase A Deficiency in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, SH; Cherry, M; Desnick, RJ; Goldberg, MA; Hempel, D; Ioannou, YA; Li, C; van Rooijen, N; Yew, NS; Zhu, Y; Ziegler, RJ1

Other Studies

1 other study(ies) available for clodronic acid and alpha-Galactosidase A Deficiency

ArticleYear
Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease.
    Human gene therapy, 2002, May-20, Volume: 13, Issue:8

    Topics: Adenoviridae; alpha-Galactosidase; Animals; Clodronic Acid; Dose-Response Relationship, Drug; Fabry Disease; Female; gamma-Globulins; Genetic Therapy; Genetic Vectors; Humans; Kupffer Cells; Liver; Mice; Mice, Inbred BALB C; Transduction, Genetic

2002